Assessment of programmed cell death ligand-1 expression with multiple immunohistochemistry antibody clones in non-small cell lung cancer

BACKGROUND: Programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) have been identified as novel targets for immunotherapy, with PD-L1 as a potential predictive biomarker. However, a specific antibody for PD-L1 expression is an immediate requirement. Meanwhile, the clinicopatholog...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Thorac Dis
Autores principales: Pang, Chen, Yin, Limei, Zhou, Xiaojuan, Lei, Chuanfen, Tong, Ruizhan, Huang, Meijuan, Gong, Youling, Ding, Zhenyu, Xue, Jianxin, Zhu, Jiang, Wang, Yongsheng, Ren, Li, Zhou, Lin, Wang, Jin, Peng, Feng, Zhou, Qiao, Lu, You
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5864642/
https://ncbi.nlm.nih.gov/pubmed/29607153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.01.124
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares